Comparative Pharmacology
Head-to-head clinical analysis: GENTACIDIN versus GENTAFAIR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GENTACIDIN versus GENTAFAIR.
GENTACIDIN vs GENTAFAIR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminoglycoside antibiotic that binds to the 30S ribosomal subunit, causing misreading of mRNA and inhibiting protein synthesis.
Gentamicin is an aminoglycoside antibiotic that binds to the 30S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis and causing misreading of mRNA, leading to cell death.
5-7 mg/kg IV every 24 hours.
Gentamicin 3-5 mg/kg IV or IM once daily for serious infections; alternatively, 1.5-2 mg/kg IV or IM every 8 hours.
None Documented
None Documented
2-3 hours in adults with normal renal function; extended to 24-48 hours in anuria or severe renal impairment, requiring dose adjustment.
2-3 hours (normal renal function); may extend to 24-48 hours in severe renal impairment, necessitating dose adjustment.
Renal: 95-98% unchanged via glomerular filtration; biliary/fecal: <2%.
Renal: over 90% unchanged via glomerular filtration; minor biliary (<1%).
Category C
Category C
Aminoglycoside Antibiotic
Aminoglycoside Antibiotic